Breast invasive carcinoma (BRCA) patients with low KLRB1 levels were linked to advanced disease stages, poor prognosis, and a decreased survival probability compared to those with high KLRB1 expression. The gene discussed is KLRB1; the disease is invasive breast carcinoma.